Medical Cannabis is highly effective in reducing pain levels, improving mood, reducing anxiety, and promoting restorative sleep with few or no unwanted side effects.

André Steiner lists the benefits of investing in marijuana in the Caribbean country: local culture, climate, favorable laws, and government incentives

New resolution allows planting by universities and pharmaceutical industries, requiring maximum security systems and total traceability of the plant

Botswana has published new rules for cannabis, with THC limits, strict licenses, and control over cultivation, transportation, research, and export

Resumption of review by Anvisa and final deadline from STJ for cultivation define the sector's direction in the first quarter of the year

Letter brings together experts from across the country and includes UFLA participation

New methodology based on hyperspectral imaging allows growers to anticipate the final concentration of THC and CBD, just by analyzing the leaves, without damaging the plant

New methodology based on hyperspectral imaging allows growers to anticipate the final concentration of THC and CBD, just by analyzing the leaves, without damaging the plant

The permission is exclusive for scientific research and follows strict control rules

Carolina Arruda wins the right to grow cannabis at home through a legal battle and prioritizes self-cultivation for her treatment

Brazilian entrepreneur inaugurates USA Hemp Pharmaceuticals headquarters in Goiânia, expanding the brand's operations in Brazil with a focus on medical education, white label, and technology transfer of industrial hemp

A systematic review from Erasmus University in the Netherlands reveals the potential benefits and risks of medicinal cannabis in treating conditions such as anxiety, depression, and PTSD, highlighting the importance of personalized approaches in mental health.

In the report, Andy Mannsfeld highlights that the legalization of cannabis in Germany could create far more than 27,000 jobs, contradicting conservative estimates and pointing to an even more significant socioeconomic impact in the country.

With an initial investment of approximately R$106 million, the company offers sustainable innovation, quality, and pharmaceutical standards of excellence

Expert explains that the increase in demand for cannabis arises after the government made a 'more potent' version available

In his debut column for Sechat, veterinarian Erik Amazonas evaluates the latest statement issued by the Federal Council of Veterinary Medicine (CFMV) regarding the prescription of cannabis-derived products.

It is certain that medicinal cannabis is gaining prominence in the health field, but is it a good remedy for our pets?

In another column for Sechat, The Green Hub's Head of Business Marcelo De Vita Grecco evaluates the current regulatory scenario of cannabis in Brazil and suggests the possibility of a plan B, at a time when the focus is on the resumption of the legislative process.